Media Center

Read the latest news from INA and all of the official press releases.

Bali International Hospital Establishes Global Partnerships
April 26, 2025

Bali International Hospital Establishes Global Partnerships

Bali International Hospital (BIH) introduced international medical partners, health experts and clinicians in the Special Economic Zone (SEZ) of Sanur, Bali, on Friday (25/04). BIH occupies a unique position as a medical tourism and referral destination, serving patients from home and abroad.

BIH introduced Icon Cancer Center, one of the largest integrated cancer service providers in the world with more than 350 specialists and approximately 3.5 million patient interactions annually. The Icon Cancer Center became operational at BIH in May 2025. This is a milestone in history. For the first time, foreign doctors were allowed to practice in Indonesia under the management of the Sanur Health SEZ region.

The event also appreciated the role of Indonesia Healthcare Corporation (IHC) or PT Pertamina Bina Medika as the operator and Indonesia Investment Authority (INA) as the state endowment investor.

Read more

INA in the News

INA, ESR, Mitsubishi Jointly Investing in Three Indonesian Logistics Parks

INA, ESR Group and MC Urban Development Indonesia (MCUDI) have partnered up to invest in three logistics parks in Indonesia, developed and managed by ESR. The trio said they were also exploring options for additional joint investments in the sector. The three property assets are in Cikarang and Kawarang. The two assets in Cikarang have an expected completion date of May and June 2023, while the property in Karawang is set to start construction in June 2023.

INA's Performance Will be Tested in Election Year After the 2022 Net Profit Increased

Indonesia Investment Authority (INA) has recorded excellent performance throughout 2022, both in terms of profit and assets. However, the continuation of this performance will be tested because Indonesia is now in an election year. Economist Yusuf Rendy Manilet, of the Center of Reform on Economics (Core) Indonesia, said INA was considered capable of maintaining its performance in an election year if there was no friction disrupting the political and security climate in the country.

Mitratel distributes IDR 1.26 trillion dividends

PT Dayamitra Telekomunikasi Tbk or Mitratel (MTEL) has announced the distribution of cash dividends worth a total of IDR 1.76 trillion, an equivalent to 99% of 2022 net profit. Currently, 28.15% of Mitratel's shares are publicly owned, with Indonesia Investment Authority (INA) and the Government of Singapore Investment Corporation (GIC), Abu Dhabi Growth Fund (ADG), and Abu Dhabi Investment Authority (ADIA) as the anchor investors.

Indonesia Sovereign Fund steps up EV plans with China's CATL

The Indonesia Investment Authority is setting up a special fund with Chinese battery giant Contemporary Amperex Technology (CATL) to help develop the emerging industry in the Southeast Asian country. Stefanus Ade Hadiwidjaja, chief investment officer of the sovereign wealth fund tasked with attracting foreign capital and investing in growth areas in Indonesia, told Nikkei Asia that the planned EV Ecosystem Fund with CATL will explore investments in electric vehicle-related sectors in Indonesia.

Indonesia Investment Authority and U.S. International DFC execute Memorandum of Understanding to catalyze investments in Indonesia

Indonesia Investment Authority (INA) and U.S. International Development Finance Corporation (DFC) have taken a significant step towards promoting economic development in Indonesia by signing a Memorandum of Understanding (MoU). As part of the MoU, DFC and INA will collaborate to identify investment opportunities throughout Indonesia that align with their respective investment mandates, demonstrating a strong potential for strategic and developmental impact.

The Impact of INA and SRF’s Investment in Kimia Farma

The capital injection by the Indonesia Investment Authority and Silk Road Fund to PT Kimia Farma Tbk and PT Kimia Farma Apotek) opened opportunities for the company's expansion into international markets. Associate Director of Research and Investment Pilarmas Investindo Sekuritas Maximilianus Nico Demus said: "This expansion is also considered to be able to open Kimia Farma's access to experts from global investors.” He added that Kimia Farma's capital structure and liquidity will strengthen. “More than that, the company also can open the door to the international market for Kimia Farma's business and network, from the retail and health services."